Myomo (MYO) Accumulated Depreciation & Amortization (2016 - 2024)
Myomo posted quarterly Accumulated Depreciation & Amortization of $994909.0 for Q4 2024, up 26.1% year-on-year from $788999.0 in Q1 2024, and up 26.1% on a QoQ basis from $788999.0 in Q4 2023.
Myomo (MYO) has 9 years of Accumulated Depreciation & Amortization data on file, last reported at $994909.0 in Q4 2024.
- For the quarter ending Q4 2024, Accumulated Depreciation & Amortization rose 26.1% year-over-year to $994909.0; the trailing twelve-month figure through Dec 2024 stood at $994909.0 (up 26.1% YoY), and the FY2024 full-year result was $994909.0, up 26.1% from the prior year.
- Accumulated Depreciation & Amortization for Q4 2024 stood at $994909.0, up from $788999.0 in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $994909.0 in Q4 2024 and bottomed at $287445.0 in Q4 2020.
- The 5-year median for Accumulated Depreciation & Amortization is $633485.0 (2022), against an average of $627346.4.
- The widest annual swing landed in 2021, when Accumulated Depreciation & Amortization jumped 50.25%; it then grew 24.55% in 2023.
- A 5-year view of Accumulated Depreciation & Amortization shows it stood at $287445.0 in 2020, then surged by 50.25% to $431894.0 in 2021, then surged by 46.68% to $633485.0 in 2022, then advanced by 24.55% to $788999.0 in 2023, then climbed by 26.1% to $994909.0 in 2024.
- The last three Accumulated Depreciation & Amortization figures came in at $994909.0 (Q4 2024), $788999.0 (Q4 2023), and $633485.0 (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 994,909.00 |
| Dec 31, 2024 | 994,909.00 |
| Dec 31, 2023 | 788,999.00 |
| Dec 31, 2023 | 788,999.00 |
| Dec 31, 2022 | 633,485.00 |
| Dec 31, 2022 | 633,485.00 |
| Dec 31, 2021 | 431,894.00 |
| Dec 31, 2021 | 431,894.00 |
| Dec 31, 2020 | 287,445.00 |
| Dec 31, 2020 | 287,445.00 |
| Dec 31, 2019 | 192,277.00 |
| Dec 31, 2019 | 192,277.00 |
| Dec 31, 2018 | 100,118.00 |
| Dec 31, 2018 | 100,118.00 |
| Dec 31, 2017 | 31,760.00 |
| Dec 31, 2017 | 31,760.00 |
| Dec 31, 2016 | 20,345.00 |
| Dec 31, 2016 | 20,345.00 |